CLINICAL_TRIALS
withdrawal
· 2017-05-22
Clinical Trial Update: Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers [Phase 1, Phase 2]
Summary
Clinical trial update on atomoxetine's effects on nicotine response and stress response in smokers, involving Phase 1 and Phase 2 studies, which has been withdr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Nicotine Dependence | Phase 1, Phase 2 | Status: WITHDRAWN